Drugs

Imiquimod

Imiquimod

Other Names: Aldara, Zyclara Drug Class: Opportunistic Infections and Coinfections
What is imiquimod?

What is imiquimod?

Imiquimod is a prescription medicine approved by the U.S. Food and Drug Administration (FDA). It is a cream for topical use only. The cream is available in three strengths: 2.5%, 3.75%, and 5%. All three strengths are approved to treat actinic keratosis (AK)—a skin condition that may develop into skin cancer—on the face or scalp in adults with healthy immune systems. Imiquimod cream 5% is approved to treat some types of primary superficial basal cell carcinoma (sBCC)—a type of skin cancer—in adults with healthy immune systems.

Additionally, imiquimod creams 3.75% and 5% are approved to treat external genital warts (warts on the outside of the genitals) and perianal warts (warts around the outside of the anus) in people 12 years of age and older. External genital and perianal warts are caused by the human papillomavirus (HPV). HPV is an opportunistic infection (OI) of HIV. An OI is an infection that occurs more frequently or is more severe in people with weakened immune systems—such as people with HIV—than in people with healthy immune systems. To learn more about OIs, read the AIDSinfo What is an Opportunistic Infection? fact sheet.

How is imiquimod used in people with HIV?

How is imiquimod used in people with HIV?

The Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents include recommendations on the uses of imiquimod in people with HIV.

Using a medicine as indicated on the medicine label is called on-label use; using the medicine in a different way is called off-label use. Off-label use, for example, can include using a drug for a different disease or medical condition. Good medical practice and the best interests of a patient sometimes require that a medicine be used off-label.

The guidelines include recommendations on the following uses of imiquimod:

On-label use:

  • Treat external genital warts caused by HPV
Off-label use:
  • Treat herpes simplex virus (HSV) disease in people for whom the medicine acyclovir will not effectively treat HSV (also known as acyclovir-resistant HSV)

The above list may not include all of the HIV-related uses of imiquimod recommended in the guidelines. Some recommended uses, such as uses in certain rare circumstances, may have been omitted.

What should I tell my health care provider before using imiquimod?

What should I tell my health care provider before using imiquimod?

Before using imiquimod, tell your health care provider:

  • If you are allergic to imiquimod or any other medicines.
  • About any medical conditions you have or have had, for example, skin or immune system problems.
  • About anything that could affect your ability to use imiquimod, such as difficulty with applying a cream to the affected area or trouble with remembering a scheduled dose.
  • If you are pregnant or plan to become pregnant. Whether imiquimod can harm an unborn baby is unknown. Imiquimod should be used during pregnancy only if the potential benefit justifies the potential risk to the unborn baby. Talk to your health care provider about possible risks with using imiquimod when pregnant.
  • If you are breastfeeding or plan to breastfeed. Do not breastfeed if you have HIV.
  • About other prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Imiquimod may affect the way other medicines or products work, and other medicines or products may affect how imiquimod works. Tell your health care provider if you have had other treatments for genital or perianal warts, actinic keratosis, or superficial basal cell carcinoma. Imiquimod should not be used until your skin has healed from other treatments. Ask your health care provider if there are interactions between imiquimod and the other medicines you take.

Ask your health care provider about possible side effects from imiquimod. Your health care provider will tell you what to do if you have side effects.

How should I use imiquimod?

How should I use imiquimod?

Use imiquimod according to your health care provider’s instructions. Your health care provider will tell you how much imiquimod to use and when to use it. Before you start imiquimod and each time you get a refill, read any printed information that comes with your medicine.

How should imiquimod be stored?

How should imiquimod be stored?

  • Store imiquimod creams 2.5% and 3.75% at room temperature, 59°F to 86°F (15°C to 30°C). Do not freeze. Store imiquimod cream pumps upright.
  • Store imiquimod cream 5% at 39°F to 77°F (4°C to 25°C). Do not freeze.
  • Keep imiquimod in the container that it came in and keep the container tightly closed.
  • Do not use imiquimod if the original seal over the container opening is broken or missing.
  • Throw away imiquimod that is no longer needed or expired (out of date). Follow FDA guidelines on how to safely dispose of unused medicine.
  • Keep imiquimod and all medicines out of reach of children.

Where can I find more information about imiquimod?

Where can I find more information about imiquimod?

More information about imiquimod is available:

The above Patient Version drug summary is based on the following FDA label(s): Cream (2.5% and 3.75%); Cream (5%).

Last Reviewed: February 27, 2019